sitagliptin "medical valley" 50 mg filmovertrukne tabletter
medical valley invest ab - sitagliptinhydrochlorid - filmovertrukne tabletter - 50 mg
sitagliptin "mylan" 100 mg filmovertrukne tabletter
mylan ab - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg
sitagliptin "mylan" 50 mg filmovertrukne tabletter
mylan ab - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg
sitagliptin "laurus" 100 mg filmovertrukne tabletter
laurus generics gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg
sitagliptin "laurus" 50 mg filmovertrukne tabletter
laurus generics gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg
sitagliptin "reddy" 100 mg filmovertrukne tabletter
reddy holding gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 100 mg
sitagliptin "reddy" 50 mg filmovertrukne tabletter
reddy holding gmbh - sitagliptinhydrochloridmonohydrat - filmovertrukne tabletter - 50 mg
galvus
novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.
jalra
novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).
xiliarx
novartis europharm limited - vildagliptin - diabetes mellitus, type 2 - narkotika anvendt i diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgængelige data på forskellige kombinationer).